110 related articles for article (PubMed ID: 14967092)
1. [Paraoxonase 1 gene 192 polymorphism, physical activity and lipoprotein in women].
Manresa JM; Tomás M; Ribes E; Pi-Figueras M; Aguilera A; Sentí M; Marrugat J
Med Clin (Barc); 2004 Feb; 122(4):126-9. PubMed ID: 14967092
[TBL] [Abstract][Full Text] [Related]
2. Effect of physical activity on lipid levels in a population-based sample of men with and without the Arg192 variant of the human paraoxonase gene.
Sentí M; Aubó C; Elosua R; Sala J; Tomás M; Marrugat J
Genet Epidemiol; 2000 Mar; 18(3):276-86. PubMed ID: 10723110
[TBL] [Abstract][Full Text] [Related]
3. Effect of simvastatin therapy on paraoxonase activity and related lipoproteins in familial hypercholesterolemic patients.
Tomás M; Sentí M; García-Faria F; Vila J; Torrents A; Covas M; Marrugat J
Arterioscler Thromb Vasc Biol; 2000 Sep; 20(9):2113-9. PubMed ID: 10978257
[TBL] [Abstract][Full Text] [Related]
4. Paraoxonase1-192 polymorphism modulates the nonfatal myocardial infarction risk associated with decreased HDLs.
Sentí M; Tomás M; Marrugat J; Elosua R;
Arterioscler Thromb Vasc Biol; 2001 Mar; 21(3):415-20. PubMed ID: 11231922
[TBL] [Abstract][Full Text] [Related]
5. Interaction of paraoxonase-192 polymorphism with low HDL-cholesterol in coronary artery disease risk.
Mendonça MI; Dos Reis RP; Freitas AI; Pereira A; Sousa AC; Freitas S; Ornelas I; Freitas C; Brehm A; Araújo JJ
Rev Port Cardiol; 2010 Apr; 29(4):571-80. PubMed ID: 20734577
[TBL] [Abstract][Full Text] [Related]
6. Effect of paraoxonase 1 polymorphisms on the response of lipids and lipoprotein-associated enzymes to treatment with fluvastatin.
Christidis DS; Liberopoulos EN; Kakafika AI; Miltiadous GA; Liamis GL; Kakaidi B; Tselepis AD; Cariolou MA; Elisaf MS
Arch Med Res; 2007 May; 38(4):403-10. PubMed ID: 17416287
[TBL] [Abstract][Full Text] [Related]
7. Interaction between the Gln-Arg 192 variants of the paraoxonase gene and oleic acid intake as a determinant of high-density lipoprotein cholesterol and paraoxonase activity.
Tomás M; Sentí M; Elosua R; Vila J; Sala J; Masià R; Marrugat J
Eur J Pharmacol; 2001 Dec; 432(2-3):121-8. PubMed ID: 11740946
[TBL] [Abstract][Full Text] [Related]
8. PON1Q192R polymorphism is associated with lipid profile in Mexican men with Mayan ascendancy.
Pérez-Herrera N; May-Pech C; Hernández-Ochoa I; Castro-Mañé J; Rojas-García E; Borja-Aburto VH; Castillo-Burguete T; Quintanilla-Vega B
Exp Mol Pathol; 2008 Oct; 85(2):129-34. PubMed ID: 18582459
[TBL] [Abstract][Full Text] [Related]
9. High triglycerides and low high-density lipoprotein cholesterol lipid profile in rheumatoid arthritis: A potential link among inflammation, oxidative status, and dysfunctional high-density lipoprotein.
Rodríguez-Carrio J; Alperi-López M; López P; López-Mejías R; Alonso-Castro S; Abal F; Ballina-García FJ; González-Gay MÁ; Suárez A
J Clin Lipidol; 2017; 11(4):1043-1054.e2. PubMed ID: 28662934
[TBL] [Abstract][Full Text] [Related]
10. Low protective PON1 lactonase activity in an Arab population with high rates of coronary heart disease and diabetes.
Gugliucci A; Caccavello R; Nassar H; Abu Ahmad W; Sinnreich R; Kark JD
Clin Chim Acta; 2015 May; 445():41-7. PubMed ID: 25801214
[TBL] [Abstract][Full Text] [Related]
11. The paraoxonase promoter polymorphism (-107)T>C is not associated with carotid intima-media thickness in Sicilian hypercholesterolemic patients.
Campo S; Sardo MA; Trimarchi G; Bonaiuto M; Castaldo M; Fontana L; Bonaiuto A; Bitto A; Saitta C; Saitta A
Clin Biochem; 2004 May; 37(5):388-94. PubMed ID: 15087255
[TBL] [Abstract][Full Text] [Related]
12. High-density lipoprotein cholesterol and paraoxonase 1 (PON1) genetics and serum PON1 activity in prepubertal children in Spain.
Garcés C; López-Simón L; Rubio R; Benavente M; Cano B; Ortega H; de Oya M
Clin Chem Lab Med; 2008; 46(6):809-13. PubMed ID: 18601602
[TBL] [Abstract][Full Text] [Related]
13. Both paraoxonase-1 genotype and activity do not predict the risk of future coronary artery disease; the EPIC-Norfolk Prospective Population Study.
Birjmohun RS; Vergeer M; Stroes ES; Sandhu MS; Ricketts SL; Tanck MW; Wareham NJ; Jukema JW; Kastelein JJ; Khaw KT; Boekholdt SM
PLoS One; 2009 Aug; 4(8):e6809. PubMed ID: 19710913
[TBL] [Abstract][Full Text] [Related]
14. The paraoxonase-1 codon 192 polymorphism is associated with fasting total cholesterol and LDL-cholesterol concentrations only in postmenopausal women. The REGICOR study.
Senti M; Tomás M; Elosual R; Sala J; Masiá R; Marrugat J
Clin Chem Lab Med; 2002 Jul; 40(7):677-83. PubMed ID: 12241013
[TBL] [Abstract][Full Text] [Related]
15. Paraoxonase polymorphisms PON1 192 and 55 and longevity in Italian centenarians and Irish nonagenarians. A pooled analysis.
Rea IM; McKeown PP; McMaster D; Young IS; Patterson C; Savage MJ; Belton C; Marchegiani F; Olivieri F; Bonafe M; Franceschi C
Exp Gerontol; 2004 Apr; 39(4):629-35. PubMed ID: 15050299
[TBL] [Abstract][Full Text] [Related]
16. Effects of intronic and exonic polymorphisms of paraoxonase 1 (PON1) gene on serum PON1 activity in a Korean population.
Eom SY; Kim YS; Lee CJ; Lee CH; Kim YD; Kim H
J Korean Med Sci; 2011 Jun; 26(6):720-5. PubMed ID: 21655055
[TBL] [Abstract][Full Text] [Related]
17. Association between serum paraoxonase (PON1) gene promoter T(-107)C polymorphism, PON1 activity and HDL levels in healthy Sicilian octogenarians.
Campo S; Sardo MA; Trimarchi G; Bonaiuto M; Fontana L; Castaldo M; Bonaiuto A; Saitta C; Bitto A; Manduca B; Riggio S; Saitta A
Exp Gerontol; 2004 Jul; 39(7):1089-94. PubMed ID: 15236768
[TBL] [Abstract][Full Text] [Related]
18. Small Dense Low Density Lipoprotein Cholesterol, Paraoxonase 1 and Lipid Profile in Postmenopausal Women: Quality or Quantity?
Mogarekar MR; Kulkarni SK
Arch Med Res; 2015 Oct; 46(7):534-8. PubMed ID: 26348135
[TBL] [Abstract][Full Text] [Related]
19. Paraoxonase (Pon1) Q192R polymorphism and serum Pon1 activity in diabetic patients on maintenance hemodialysis.
Zhang B; Eto S; Fan P; Bian C; Shimoji E; Saito T; Saku K
Clin Nephrol; 2003 Oct; 60(4):257-65. PubMed ID: 14579940
[TBL] [Abstract][Full Text] [Related]
20. PON1 M/L55 mutation protects high-risk patients against coronary artery disease.
Oliveira SA; Mansur AP; Ribeiro CC; Ramires JA; Annichino-Bizzacchi JM
Int J Cardiol; 2004 Mar; 94(1):73-7. PubMed ID: 14996478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
